News
ZRSEF
36.22
NaN%
--
DocMorris shareholders back board, reaffirm digital health strategy and 2026 break-even goal
TipRanks · 05/12 18:02
DocMorris (DOCM) Gets a Buy from Jefferies
TipRanks · 05/05 12:27
Jefferies Reaffirms Their Buy Rating on DocMorris (DOCM)
TipRanks · 04/27 12:17
DocMorris (DOCM) Receives a Hold from Barclays
TipRanks · 04/23 06:47
UBS Remains a Sell on DocMorris (DOCM)
TipRanks · 04/21 09:45
DocMorris (DOCM) Receives a Hold from Deutsche Bank
TipRanks · 04/17 08:46
Barclays Sticks to Their Hold Rating for DocMorris (DOCM)
TipRanks · 04/17 06:15
DocMorris (DOCM) Receives a Sell from UBS
TipRanks · 04/16 09:59
Buy Rating Backed by Strong 2026 Start, Balanced Segment Growth and Clear Path to Q4 Profit Break-Even
TipRanks · 04/16 06:25
DocMorris Q1 2026 Growth and Profitability Gains Reinforce Path to Break-Even
TipRanks · 04/16 05:33
DocMorris Board Urges Shareholders to Block ‘Creeping Takeover’ at May General Meeting
TipRanks · 04/16 05:32
DocMorris AG Charts Costly Yet Credible Turnaround
TipRanks · 03/27 00:22
DocMorris price target lowered to CHF 4.45 from CHF 8.10 at Berenberg
TipRanks · 03/24 17:52
DocMorris (DOCM) Gets a Sell from UBS
TipRanks · 03/24 09:35
DocMorris price target lowered to CHF 4.50 from CHF 7 at Deutsche Bank
TipRanks · 03/23 16:45
Berenberg Bank Keeps Their Hold Rating on DocMorris (DOCM)
TipRanks · 03/23 10:17
Deutsche Bank Keeps Their Hold Rating on DocMorris (DOCM)
TipRanks · 03/21 15:05
DocMorris (DOCM) Gets a Sell from UBS
TipRanks · 03/19 10:59
Barclays Keeps Their Hold Rating on DocMorris (DOCM)
TipRanks · 03/19 08:55
DocMorris: Credible Turnaround and Improving EBITDA Outlook Support Buy Rating
TipRanks · 03/19 06:55
More
Webull provides a variety of real-time ZRSEF stock news. You can receive the latest news about DocMorris through multiple platforms. This information may help you make smarter investment decisions.
About ZRSEF
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others